tiprankstipranks
Trending News
More News >
Knight Therapeutics (TSE:GUD)
TSX:GUD

Knight Therapeutics (GUD) Revenue

Compare
108 Followers

Knight Therapeutics Revenue

Knight Therapeutics had a revenue of 133.11M in the quarter ending Dec 31, 2025, with 9.51%. This bring the company's revenue in the last twelve months to 450.09M, Decreased 8.76%. In the fiscal year ending Dec 31, 2025, Knight Therapeutics had annual revenue of 450.09M with 21.22% growth.
Revenue (ttm)
450.09M
Revenue Growth
18.70%
P/S Ratio
1.40
Revenue/Employee
C$604,145
Employees
745
Market Cap
C$628.40M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
450.09M78.78M+21.22%
Dec 31, 2024
371.30M43.10M+13.13%
Dec 31, 2023
328.20M34.64M+11.80%
Dec 31, 2022
293.56M50.09M+20.57%
Dec 31, 2021
243.48M43.96M+22.03%
Dec 31, 2020
199.52M152.06M+320.39%
Dec 31, 2019
47.46M34.96M+279.69%
Dec 31, 2018
12.50M3.87M+44.78%
Dec 31, 2017
8.63M